Germline mutations in CHEK2 (OMIM: 604373), in particular truncating mutations, are considered causative of Li Fraumeni (like) syndrome 2 (LFS2) (OMIM: 609265) and are associated with increased cancer risk, with lymphoma belonging to the disease spectrum of LFS59,60. Here, CHEK2 is linked to cancer.